Axsendo Clinical Research · Peak Heart & Vascular · Phoenix, Arizona
(602) 730-9500 [email protected]
Now Enrolling · Phoenix, AZ
ATTAIN-PAD Study · Eli Lilly

Do you experience
leg pain or cramping
when you walk?

You may have peripheral artery disease (PAD). A local clinical research study is now enrolling adults with PAD right here in Phoenix — at Peak Heart & Vascular.

No-cost study-related care Access to specialist physicians Help shape future treatments
Study Name
ATTAIN-PAD
Sponsor
Eli Lilly & Company
Location
Phoenix, Arizona
Status
● Enrolling
Free · No Obligation
See if you qualify
Takes less than 2 minutes. Our team will follow up within 24 hours.

By submitting, you agree to be contacted by the Peak Heart & Vascular research team regarding this study. Your information will not be sold or shared with third parties. Submitting does not guarantee enrollment.

✓
Thank you!

Our research team will be in touch within 24 hours. You can also learn more about our practice at peakheart.com.

Visit Peak Heart →
Understanding Your Condition

What is Peripheral Artery Disease?

Peripheral artery disease (PAD) is a common circulatory problem where narrowed arteries reduce blood flow to the limbs — most often the legs. PAD is caused by the buildup of fatty deposits in artery walls, the same process that causes coronary artery disease.

Many people with PAD experience pain, cramping, or fatigue in their legs when walking or climbing stairs — a symptom called claudication. If left untreated, PAD can progress and significantly impact quality of life.

🦵
Leg pain or cramping when walking
😴
Leg fatigue or heaviness
❄️
Cold feeling in lower legs or feet
🔴
Sores on toes, feet, or legs
⚡
Weakness or numbness in legs
🫀
Discomfort relieved by rest
8–12M
Americans are estimated to be living with peripheral artery disease today.
"Researchers are actively looking for more treatment options for this frustrating condition. A local clinical research study is currently seeking adults with PAD who are already receiving standard of care."
— ATTAIN-PAD Study, Eli Lilly & Company
Why Participate

Reasons to consider joining this study

Clinical research is a chance to help potentially shape the future of medicine — with access to medical specialists, expert study-related care, and support resources at no cost to you.

01
No-cost study-related medical care
All study visits, tests, and investigational treatments are provided at no cost to participants. No insurance required.
02
Access to expert cardiovascular specialists
You'll receive care from Peak Heart & Vascular's board-certified cardiologists and vascular specialists throughout the study.
03
Help advance treatment options for PAD
By participating, you contribute to research that could help millions of adults living with peripheral artery disease.
Eligibility

Do you qualify?

The ATTAIN-PAD Study is looking for adults who meet specific criteria. Only the study team can confirm your eligibility after a screening visit — but here are the general requirements.

This is general eligibility information only. A qualified member of the Peak Heart & Vascular research team will determine if you qualify during a confidential screening visit.
✓
Adults 18 years of age or older
✓
Diagnosed with peripheral artery disease (PAD)
✓
Currently receiving standard of care or treatment for PAD — such as medication, lifestyle changes, or other therapies
✓
Experience leg pain, cramping, or fatigue related to PAD symptoms
✓
Located near Phoenix, Arizona and able to attend scheduled study visits at Peak Heart & Vascular
You may not qualify if you
Are pregnant or planning to become pregnant during the study period
Have certain other serious medical conditions — the study team will review
Are currently enrolled in another clinical research study
The Process

How it works

Getting started is simple. There's no commitment required to submit your interest.

01
Submit your interest
Fill out the short form above with your name, contact info, and ZIP code. It takes less than 2 minutes and there's no obligation.
→ Takes 2 minutes
02
Our team contacts you
A member of the Peak Heart & Vascular research team will call or email you within 24 hours to answer questions and discuss next steps.
→ Within 24 hours
03
Attend a screening visit
If it seems like a potential fit, you'll be invited to a no-cost screening visit at our Phoenix office to confirm eligibility. No commitment required.
→ No cost, no obligation
Study Location

Peak Heart & Vascular
Phoenix, Arizona

The ATTAIN-PAD Study is being conducted at Peak Heart & Vascular in partnership with Axsendo Clinical Research — one of the nation's leading clinical research site networks. Peak Heart & Vascular is a premier cardiology practice serving patients throughout Phoenix and the surrounding communities.

✓
Board-certified cardiovascular physicians
✓
Full Phase I–IV research capabilities
✓
Private exam rooms & comfortable waiting areas
✓
On-site lab & diagnostic imaging
✓
Ample free parking
✓
Weekend consultation & screening hours available
Research Site
Axsendo Clinical Research
at Peak Heart & Vascular
📍
Address
10825 W. McDowell Rd., Suite 320
Avondale, AZ 85392
📞
✉️
🌐
🗓️
Hours
Mon–Fri 8am–5pm
Weekend screenings available
Ready to take the next step?

Find out if the ATTAIN-PAD Study is right for you

No cost. No commitment. Just a 2-minute form and our team will handle the rest.

See If You Qualify →
Important Information

The ATTAIN-PAD Study is sponsored by Eli Lilly and Company. This page is for informational purposes only and does not constitute medical advice. Clinical research involves investigational treatments that have not yet been approved by the FDA. Only a qualified physician can determine your eligibility for participation. Participation is voluntary and you may withdraw at any time.

Image & Content Notice

The image depicted on associated materials contains models and is being used for illustrative purposes only. Content on this page is derived from sponsor-approved messaging materials provided by Eli Lilly and Company and Clinical Trial Media (CTM). Study details are subject to change. For the most current information, visit peakheart.com . © 2025 Eli Lilly and Company. All Rights Reserved.